Fair Medicaid Drug Payment Act of 2007

HR616/S511 - Access to Durable Medical Equipment Act HR203 - Medicare Fraud Prevention Act of 2009 HR27 - Medicare Fraud Prevention and Enforcement Act of 2009 HR574 - Medicare Home Infusion Therapy Coverage Act of 2009 S266 - Medicare Prescription Drug Gap Reduction Act of 2009 HR2560/S1131 - Independence At Home Act HR1970/S956 - Preserve Patient Access to the Reputable DMEPOS Providers Act of 2009 HR3700/S1951 - Fair Medicaid Drug Payment Act (From 110th Congress)/Concept to Include Medicaid Average Manufacturer Price Reimbursement Formula in Health Care Reform (Public Law 110-275) Medicare Improvements for Patients and Providers Act of 2008 Sections on Medicare DMEPOS (Docket Number: CMS1561IFC) Medicare Program; Changes to the Competitive Acquisition of Certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) by Certain Provisions of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) (Docket Number: CMS-1540-F) Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2007; Certain Provisions Concerning Competitive Acquisition for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS); Accreditation of DMEPOS Suppliers (Docket Number: CMS-6006-F) Medicare Program: Surety Bond Requirement for Suppliers of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Solicitation for Comments on the Draft CMS Model Transition Letter for Calendar Year 2010 Draft 2010 Medicare Part D Call Letter

Client expense: $194,415 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE

S. 1951 & H.R. 3700, Fair Medicaid and Drug Payment Act of 2007; health reform bills.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1951 & H.R. 3700, Fair Medicaid and Drug Payment Act of 2007; H.R. 1, The American Recovery and Reinvestment Act of 2009.

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

-H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. -S. 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; -S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -S. 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -H.R. 4083 / S. 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; -S. 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.

Client expense: $1,440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

-H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. -S. 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; -S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -S. 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -H.R. 4083 / S. 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; -S. 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.

Client expense: $1,440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to the implementation of Section 501 (c) of the 2005 Deficit Reduction Act; S.1951 and H.R. 3700, The Fair Medicaid Drug Payment Act, Section 2 (b) Prior Authorization Programs; S. 1887, and H.R. 3061 Amending Title XVIII of the Social Security Act to ensure access to critical medications under Medicare Part D; S. 3101 and H.R. 6331, The Medicare Improvements for Patients and Providers Act, provisions relating to six classes of clinical concern under Medicare Part D.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the implementation of Section 501 (c) of the 2005 Deficit Reduction Act; S. 1951 and H.R. 3700, The Fair Medicaid Drug Payment Act, Section 2 (b) Prior Authorization Programs; S. 1887 and H.R. 3061 Amending Title XVIII of the Social Security Act to ensure access to critical medications under Medicare Part D.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the implementation of Section 501 (c) of the 2005 Deficit Reduction Act; S. 1951 and H.R. 3700, The Fair Medicaid Drug Payment Act, Section 2 (b) Prior Authorization Programs; S. 1887. and H.R. 3061 Amending Title XVIII of the Social Security Act to ensure access to critical medications under Medicare Part D; H.R. 6331, The Medicare Improvements for Patients and Providers Act; provisions relating to six classes of clinical concern under Medicare Part D.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the implementation of Section 501 (c) of the 2005 Deficit Reduction Act; S. 1951 and H.R. 3700, The Fair Medicaid Drug Payment Act, Section 2 (b) Prior Authorization Programs; S. 1887, and H.R. 3061 Amending Title XVIII of the Social Security Act to ensure access to critical medications under Medicare Part D.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to: Medicare coverage of immunosuppressants, Medicare Part D's six classes of clinical concern, Medicaid payment for hospital-acquired conditions; The Medicare Improvements for Patients and Providers Act Technical Corrections Act; , Amending Title XVIII of the SSA to ensure access to critical medications under Medicare Part D; S. 1951 and H.R. 3700, the Fair Medicaid Drug Payment Act, S. 2320 and H.R. 3282 , the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007 Issues related to implementation of Section 5001(c) of the Deficit Reduction Act of 2005; S. 3560, QI Program Supplemental Funding Act of 2008 -- the QI bill included language to protect critical medications under Part D originally in H.R. 6331/S. 1887.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to: Medicare coverage of immunosuppressants, Medicare Part D's six classes of clinical concern, Medicaid payment for hospital-acquired conditions; The Medicare Improvements for Patients and Providers Act Technical Corrections Act; S. 1887, Medicare Access to Critical Medications Act and HR 3061, Amending Title XVIII of the SSA to ensure access to critical medications under Medicare Part D; S. 1951 and H.R. 3700, the Fair Medicaid Drug Payment Act S. 2320 and H.R. 3282, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007 Issues related to implementation of Section 5001(c) of the Deficit Reduction Act of 2005

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 1951, the Fair Medicaid Drug Payment Act of 2007, Section 2 (c). FDA Drug pedigree issues.

Client expense: $300,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE

S.1951/H.R.3700 Fair Medicaid Drug Payment Act H.R.3140 Saving our Community Pharmacies Act H.R.3191 Access to Community Pharmacy Preservation Act Medicare Improvement for Patients & Providers Act of 2008 (P.L. 110-275)

Client expense: $150,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 3700 & S. 1951, Legislation amending title XIX of the Society Security Act to ensure that individuals eligible for medical assistance under the Medicaid Program continue to have access to prescription drugs, and for other purposes Average Manufacturers Price H.R. 5839, a bill to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs

Client expense: $1,370,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Council on Environmental Quality (CEQ), Energy, Dept of, Federal Energy Regulatory Commission (FERC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

Fair Medicaid Drug Payment Act (S 1951), Genetic Information Nondiscription Act (HR 493)

Client expense: $2,895,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Security Agency (NSA), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.

Client expense: $140,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE

S. 1951/H.R. 3700, Fair Medicaid Drug Reporting Act of 2007, Section 2(c); CMS contractor coverage decisions; PL 110-275, Medicare Improvement for Patients and Providers Act of 2008.

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 1951 & H.R. 3700, Fair Medicaid and Drug Payment Act of 2007; technical corrections bill to the Medicare Improvements for Patients and Providers Act of 2008

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicaid pharmacy reimbursement and related provisions in the following bills: S. 1951 Fair Medicaid Drug Payment Act, HR 3140, Saving our Community Pharmacies Act; and S. 3101/HR 6331, Medicare Improvement for Patients and Providers Act (section 203 Pharmacy Reimbursement Under Medicaid).

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to pharmacy payments, the Medicare Part D and the competitive bidding program for diabetes. S 1951, Fair Medicaid Drug Payment Act of 2007 HR 3700, Fair Medicaid Drug Payment Act of 2007 HR 3140, Saving Our Community Pharmacies Act of 2007

Client expense: $1,870,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 S. 1544, Medicare Quality Enhancement Act of 2007 S. 1951, Fair Medicaid Drug Payment Act of 2007 H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 2770, Legislation to ensure more appropriate payment amounts for drugs and biologics under Part B of the Medicare program by excluding customary prompt pay discounts. H.R. 6331, Medicare Improvements for Patients and Providers S. 3101, Medicare Improvements for Patients and Providers S. 3118, Preserving Access to Medicare Act of 2008 S. 1954, Pharmacy Access Improvement (PhAIm) Act of 2007 H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008

Client expense: $180,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H.R. 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the Control Substances Act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.

Client expense: $470,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Saving Our Community Pharmacies Act of 2007 (H.R. 3140), The Fair Medicaid Drug Payment Act of 2007 (H.R. 3700 & S. 1951)

Client expense: Not reported · Firm income: $40,000

Government targets: Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)

Legislative and regulatory issues affecting pharmacies and retailers, including health care funding, health care programs, and the delivery of prescription drugs. H.R. 971, The Community Pharmacy Fairness Act. H.R. 3700 and S. 1951, The Fair Medicaid Drug Payment Act of 2007. H.R. 3580, Food and Drug Administration Amendments Act of 2007. H.R. 1585, Fiscal 2008 Defense Authorization - TRICARE provisions. S. 980, Ryan Haight Internet Controlled Substances Act. S. 1693, Wired for Health Care Act. H.R. 5539, the Safeguarding America's Pharmaceuticals Act of 2008. H.R. 6353, Ryan Haight Online Pharmacy Consumer Protection Act of 2008. H.R. 6331, the Medicare Patients and Providers Protection Act of 2008. H.R. 6357, Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008. H.R. 6898, Health-e Information Technology Act of 2008.

Client expense: $120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare: S 1544/HR 3370 Medicare Quality Enhancement Act of 2007 Average Manufacturer Price (AMP) formula: S 1951 Fair Medicaid Drug Payment Act of 2007 HR 3163/S 334 Healthy Americans Act; S 1693 Wired for Health Care Quality Act of 2007

Client expense: $500,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues pertaining to implementation of the Medicare Prescription drug benefit HR.1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 S.1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 S.1954, Pharmacy Access Improvement (PhAIm) Act of 2007 S.1951, Fair Medicaid Drug Payment Act of 2007 HR.3700, Fair Medicaid Drug Payment Act of 2007 HR.3140, Saving Our Community Pharmacies Act of 2007 S.3101, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008 S.2408, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 HR.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3700 & S. 1951, Legislation amending title XIX of the Society Security Act to ensure that individuals eligible for medical assistance under the Medicaid Program continue to have access to prescription drugs, and for other purposes Average Manufacturers Price H.R. 5839, a bill to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs

Client expense: $1,370,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Council on Environmental Quality (CEQ), Energy, Dept of, Federal Energy Regulatory Commission (FERC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

Medicare pharmacy reimbursement and related provisions in the following bills: S. 1951, Fair Medicaid Drug Payment Act; HR 3140, Saving Our Community Pharmacies Act; and S. 3101/HR 6331, Medicare Improvements for Patients and Providers Act (Section 203, Pharmacy Reimbursement Under Medicaid).

Client expense: $180,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE

Centers for Medicare and Medicaid Services Rule 2238-P concerning Medicaid Drug Reimbursement H.R. 3700 & S. 1951, the Fair Medicaid Drug Pricing Act

Client expense: $120,000 · Firm income: Not reported

Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE

-H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. -S. 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; -S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -S. 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -H.R. 4083 / S. 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; -S. 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.

Client expense: $1,440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 3560, QI Program Supplemental Funding Act of 2008, Amending Title XVIII of the SSA to ensure access to critical medications under Medicare Part D; S. 1951 and H.R. 3700, the Fair Medicaid Drug Payment Act; S. 2320 and H.R. 3282, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007; Issues related to implementation of Section 5001 (c) of the Deficit Reduction Act of 2005; Issues related to Medicare coverage of immunosuppressants; Issues related to Medicare Part Ds six classes of clinical concern; Issues related to Medicaid payment for hospital-acquired conditions.

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare, Healthcare Reform S 1544/HR 3370 Medicare Quality Enhancement Act of 2007 Average Manufacturer Price (AMP) formula: S 1951 Fair Medicaid Drug Payment Act of 2007 HR 3163/S 334 Healthy Americans Act; S 1693 Wired for Health Care Quality Act of 2007

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 6331/ S. 3101 - Medicare Improvements for Patients and Providers Act of 2008 (P.L. 110-275) Sections on Medicaid AMP, Medicare Part D prompt payment, DME Competitive Bidding and Accredition, Prescription Drug Pricing, Long-Term Care pharmacies, and e-prescribing H.R. 4296/ S. 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 H.R. 3700/ S. 1951 - Fair Medicaid Drug Payment Act of 2007 H.R. 3140 - Saving Our Community Pharmacies Act of 2007 S. 1827 - Pharmacist Access and Recognition in Medicare (PhARM) of 2007 H.R. 3025 - Medicare Prescription Drug Savings for Our Seniors Act of 2007 (Docket Number: CMS 4138- IFC) Medicare Program; Revisions to the Medicare Advantage and Prescription Drug Benefit Programs Sections on Prompt Payment of Clean Claims, Prescription Drug Pricing, Long-Term Care Pharmacies, Special Needs Plans, and Medication Therapy Management (Docket Number: CMS-1404-FC) Medicare Program: Changes to the Hospital Outpatient Prospective Payment System and CY 2009 Payment Rates. Final Rule with Comment Period (Docket Number: CMS-4121-F) CMS Final Rule on Prohibiting Midyear Changes to Medicare Advantage Plans (Docket Number: CMS-1403-P) CMS Amendment on Medicare Program; Revisions to Amendment of the E-Prescribing Exemption for Computer-Generated Facsimiles (Docket Number: CMS-7011-N) CMS Notice on Medicare Program: Request for Cosponsors for E-prescribing Educational Conference (Docket Number: CMS-2238-F) Medicaid Program; Multiple Source Drug Definition (Public Law 110-28 and Public Law 110-90) Medicaid's Tamper-Resistance Prescription Pad Requirement (Public Law 109-171) Deficit Reduction Act of 2005 Section on Average Manufacturers Price (AMP) (Public Law 108-173) Medicare Modernization Act (MMA) Section on Medicare Advantage and Medicare Part D Fraud, Waste, and Abuse Training Concept (No Bill Language): Medicare Part B "Provider Status" for Pharmacists Concept (No Bill Language): Changes to Medicare Part D Medication Therapy Management Benefit

Client expense: $220,970 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

S. 1951 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3700 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3140 - Saving Our Community Pharmacies Act of 2007

Client expense: $510,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Efforts to verify privacy standards for possible inclusion of Health Information Technology provisions in 2009 Stimulus PL 110-275 - Medicare Improvements for Patients and Providers Act of 2008 - Sections pertaining to Average Manufacturers Price (AMP) and exemptions for providers of Durable Medical Equipment HR 5442 - Technologies for Restoring Users' Security and Trust in Health Information Act of 2008 - Sections related to privacy HR 6357 PRO(TECH)T Act of 2008 Protecting Records, Optimizing Treatment, and Easing Communication Through Healthcare Technology Act of 2008 Sections related to patient authorization, marketing, accounting of disclosures, and breach HR 6898 - Health-e Information Technology Act of 2008 Sections related to privacy HR 3700 - Fair Medicaid Drug Payment Act of 2007 All Sections HR 7110 - Job Creation and Unemployment Relief Act of 2008 Title III Temporary Increase in Medicaid Matching Rate S 1951 - Fair Medicaid Drug Payment Act of 2007 All Sections S 1693 Wired for Health Care Quality Act Amendments related to privacy

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3700/S. 1951, Fair Medicaid Drug Payment Act of 2007, sections relating to average manufacturing price.

Client expense: $170,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare/Medicaid drug coverage including pharmacy payments, reimbursements, competition and plan administration; electronic prescribing. S 3 / HR 4 - Medicare Prescription Drug Price Negotiation Act of 2007 HR 3700 - Fair Medicaid Drug Payment Act of 2007 S 273 - Prescription Drug and Health Improvement Act of 2007 S 3118 - Preserving Access to Medicare Act of 2008 HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 HR 6331 - Medicare Improvement for Patients and Providers Act of 2008 S 3101 - Medicare Improvements for Patients and Providers Act of 2008 S 1951 - Fair Medicaid Drug Payment Act of 2007 HR 3140 - Saving Our Community Pharmacies Act of 2007 S 1507 - Access to Medicare Data Act of 2007

Client expense: $314,868 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office

Issues related to: Medicare coverage of immunosuppressants, Medicare Part D's six classes of clinical concern, Medicaid payment for hospital-acquired conditions; The Medicare Improvements for Patients and Providers Act Technical Corrections Act; , Amending Title XVIII of the SSA to ensure access to critical medications under Medicare Part D; S. 1951 and H.R. 3700, the Fair Medicaid Drug Payment Act, S. 2320 and H.R. 3282 , the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007 Issues related to implementation of Section 5001(c) of the Deficit Reduction Act of 2005; S. 3560, QI Program Supplemental Funding Act of 2008 -- the QI bill included language to protect critical medications under Part D originally in H.R. 6331/S. 1887.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Reimbursement for prescription drugs (S. 1951) (H.R. 3700) (H.R. 2770)

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

S.1951/H.R.3700 Fair Medicaid Drug Payment Act H.R.3140 Saving our Community Pharmacies Act H.R.3191 Access to Community Pharmacy Preservation Act Medicare Improvement for Patients & Providers Act of 2008 (P.L. 110-275)

Client expense: $180,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

S.1951/H.R.3700 Fair Medicaid Drug Payment Act H.R.3140 Saving our Community Pharmacies Act H.R.3191 Access to Community Pharmacy Preservation Act Medicare Improvement for Patients & Providers Act of 2008 (P.L. 110-275)

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Issues related to the implementation of Section 501 (c) of the 2005 Deficit Reduction Act; S. 1951 and H.R. 3700, The Fair Medicaid Drug Payment Act, Section 2 (b) Prior Authorization Programs; S. 1887 and H.R. 3061 Amending Title XVIII of the Social Security Act to ensure access to critical medications under Medicare Part D.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3700 & S. 1951, Legislation amending title XIX of the Society Security Act to ensure that individuals eligible for medical assistances under the Medicaid Program continue to have access to prescription drugs, and for other purposes Average Manufacturers Price, H.R. 5839, a bill to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Reimbursement for prescription drugs (S. 1951) (H.R. 3700) (H.R. 2770)

Client expense: $160,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE